Can a simple pill stop Post-Surgery sickness? new trial aims to find out
NCT ID NCT07248280
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a drug called aprepitant to standard nausea prevention can help high-risk patients avoid vomiting and nausea after outpatient surgery. About 260 adults at high risk for postoperative sickness will take either aprepitant or a placebo before surgery. The goal is to see if this extra medicine improves comfort at home during the first 48 hours after the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAUSEA AND VOMITING, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier de l'Université de Montréal (CHUM)
RECRUITINGMontreal, Quebec, H2X 0A9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A family therapy could curb early psychosis risk in youth
- Cheaper, Needle-Free option for Post-Surgery nausea in children put to the test
- Yearly TB check may shield vulnerable patients from a hidden threat
- Emergency rooms as prevention hubs: personalized advice may improve health behaviors
- Mind over matter: pain catastrophizing may predict Post-Surgery nausea
- Could a single pill after sex stop STIs in women?